Suchergebnisse - "Clinical Trial, Phase II"

PubPharm (41.173)

1

Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma : Post hoc analysis of TRIUMPH study

enthalten in: Oral oncology | 2024

von Kim, D. | Lim, S. | Kim, H. | +12

2

A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naïve adults

enthalten in: Vaccine | 2024

von Cummings, J. | Polhemus, M. | Kester, K. | +13

3

Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations : Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E

enthalten in: JCO precision oncology | 2024

von Chen, M. | Song, Z. | Yu, H. | +19

4

Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60) : a randomised, non-comparative, phase 2 study

enthalten in: The Lancet. Oncology | 2024

von Kim, S. | Ghiringhelli, F. | de la Fouchardière, C. | +25

5

LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001) : results from arm 1 of a non-randomised, single-centre, phase 1/2 study

enthalten in: The Lancet. Oncology | 2024

von Musher, B. | Rowinsky, E. | Smaglo, B. | +17

6

FRONTIER1 : a partially randomized phase 2 study assessing the safety, pharmacokinetics, and pharmacodynamics of Mim8, a factor VIIIa mimetic

enthalten in: Journal of thrombosis and haemostasis : JTH | 2024

von Lentz, S. | Chowdary, P. | Gil, L. | +5

7

MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE) : a single-centre, open-label, randomised phase 2 trial

enthalten in: The lancet. Gastroenterology & hepatology | 2024

von Timmer, F. | Geboers, B. | Ruarus, A. | +17

8

A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors : phase 1 trial interim results

enthalten in: Nature medicine | 2024

von Rappaport, A. | Kyi, C. | Lane, M. | +35

9

Switching from FOLFIRI plus cetuximab to FOLFIRI plus bevacizumab based on early tumor shrinkage in RAS wild-type metastatic colorectal cancer : A phase II trial (HYBRID)

enthalten in: Cancer medicine | 2024

von Arai, H. | Tsuda, T. | Sunakawa, Y. | +13

10

Nintedanib plus Chemotherapy for Small Cell Lung Cancer with Comorbid Idiopathic Pulmonary Fibrosis

enthalten in: Annals of the American Thoracic Society | 2024

von Ikeda, S. | Ogura, T. | Kato, T. | +14

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[4118]